Fischer Medical Ventures Limited has informed the Exchange regarding Proceedings of undefined held on September 29, 2025
FISCHER · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fischer Medical Ventures Limited held its 32nd Annual General Meeting on September 29, 2025, via video conferencing (using NSDL's platform) from 11:30 AM to 12:02 PM. A total of 67 members participated, with one corporate member representing 33,17,61,120 equity shares (51.16% of the company's equity share capital), confirming the required quorum. Chairman & Managing Director Ravindran Govindan presided over the meeting, with all key directors, the CFO (Vivek Balasubramanian), COO (Shankar Varadharajan), and Company Secretary (Aravindkumar V) in attendance. Four speaker shareholders raised queries on marketing, sales setup, foreign subsidiaries, capex plan, profitability outlook, and material subsidiaries, which were addressed by the management. The Auditors' Report and Secretarial Auditor's Report had no qualifications or adverse remarks. E-voting was conducted with Mr. Nuren Lodaya appointed as Scrutiniser.
This is a routine procedural compliance filing under SEBI LODR Regulations detailing how the AGM was conducted. It carries no direct impact on share price, as no financial results, dividends, or major corporate actions were announced in this summary.